prednison

PreclinicalSmall molecule

Novartis

prednison is one of 6 small molecule programs targeting Glucocorticoid. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

GlucocorticoidRecruiting

GlucocorticoidPreclinical

Recruiting

Competition

Competitive Landscape

6 competitors in Glucocorticoid

#DrugCompanyPhaseTrials

Mifeprex

DDanco

Approved

5 2

Pulmicort

SSalix

Approved

1 3

Enbrel

IImmunex

Phase 1

1 4

Long-Acting Beta2-Agonist

Novartis

Preclinical

1 5

Long-Acting Muscarinic Antagonists(lama)

Boehringer Ingelheim

Preclinical

1 6

prednison

Novartis

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Withdrawal1 trial

Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.

Completed· Novartis logo

Novartis·Phase 3·NCT01023815·330 enrolled

Glucocorticoid1 trial

Short-term Glucocorticoid Combined with MMF for IgG4-RD

Recruiting·WWen Zhang·N/A·NCT06663618·63 enrolled

Trial1 trial

SCMC Trial on KHE With KMP (V.2020)

Unknown status·SShanghai Children's Medical Center·Phase 1·NCT04409691·20 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for prednison. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — prednison compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for prednison. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Novartis company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: Novartis

prednison

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Withdrawal1 trial

Glucocorticoid1 trial

Trial1 trial

References

Drug Info

Quick Facts

Related News